Safety and Effectiveness of the QuickFix Small Staple

August 24, 2023 updated by: Arthrex GmbH

Prospective Study to Evaluate the Continued Safety and Effectiveness of the QuickFix Small Staple to Correct Hallux Valgus Interphalangeus

The prospective, post-market, single-center clinical study will include 45 subjects who are candidates for surgery using the Arthrex QuickFix Small Staple for Akin osteotomy to correct hallux valgus interphalangeus. The purpose of the study is to evaluate the continued safety and effectiveness of the device. Device-related adverse events as well as patient reported outcomes (VAS, FFI, FAAM, VR-12) will be collected up to 1 year postoperative.

Study Overview

Status

Terminated

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Meissen, Germany, 01662
        • Überörtliche Gemeinschaftspraxis für Chirurgie, Unfallchirurgie, Anästhesie und Endoskopie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

45 subjects, male and female, at least 18 years of age from the general population who will be treated with the Arthrex QuickFix Small Staple to correct hallux valgus interphalangeus.

Description

Inclusion Criteria:

  1. Subject requires surgery using the Arthrex QuickFix Small Staple for Akin osteotomy.
  2. Subject is 18 years of age or older.
  3. Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state).
  4. Subject signed informed consent and is willing and able to comply with all study requirements.

Exclusion Criteria:

  1. Insufficient quantity or quality of bone.
  2. Blood supply limitations and previous infections which may retard healing.
  3. Foreign-body sensitivity.
  4. Any active infection or blood supply limitations.
  5. Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
  6. Subjects that are skeletally immature.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
QuickFix Small Staple
The QuickFix Small Staple will be used for an Akin osteotomy to correct hallux valgus interphalangeus.
The Arthrex QuickFix Small Staple enables the surgeon to perform a wedge osteotomy of the first phalanx (Akin). The device is made of stainless steel and designed with barbed leg tips. The staple sizes are 8 and 10 mm wide with a 1 mm diameter.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Visual Analogue Scale (VAS)
Time Frame: preoperatively, 2 weeks, 6 week, 3 months, 6 months and 12 months postoperative
Measuring pain in the affected foot. Range 0-10 (0=best, 10=worst).
preoperatively, 2 weeks, 6 week, 3 months, 6 months and 12 months postoperative
Change of Foot Function Index (FFI)
Time Frame: preoperatively, 3 months, 6 months and 12 months postoperative
Measuring foot functionality. Range 0-100 (0=best, 100=worst)
preoperatively, 3 months, 6 months and 12 months postoperative
Change of Foot and Ankle Ability Measure (FAAM Sport)
Time Frame: preoperatively, 3 months, 6 months and 12 months postoperative
Measuring foot functionality. Range 0-100 (0=worst, 100=best)
preoperatively, 3 months, 6 months and 12 months postoperative
Change of Veterans RAND 12 Iteam Health Survey (VR-12)
Time Frame: preoperatively, 6 months and 12 months postoperative
Measuring quality of life. Range 0-100 (0=worst, 100=best)
preoperatively, 6 months and 12 months postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Tilo Schreiter, MD, Überörtliche Gemeinschaftspraxis für Chirurgie, Unfallchirurgie, Anästhesie und Endoskopie

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2021

Primary Completion (Actual)

June 29, 2023

Study Completion (Actual)

June 29, 2023

Study Registration Dates

First Submitted

February 23, 2021

First Submitted That Met QC Criteria

February 26, 2021

First Posted (Actual)

March 1, 2021

Study Record Updates

Last Update Posted (Actual)

August 28, 2023

Last Update Submitted That Met QC Criteria

August 24, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AIRR-0012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hallux Valgus Interphalangeus

Clinical Trials on QuickFix Small Staple (Arthrex)

Subscribe